Sign in

NCT06511453Active, not recruiting

Acupressure in Patients With Sickle Cell Disease

Remote Self-Administered Acupressure for Pain Management in Patients With Sickle Cell Disease

Source: ClinicalTrials.gov · Last updated 31 Jul 2026

Brief summary (registry, in English)

The proposed research is to determine the clinical efficacy and neurobiological mechanisms of acupressure analgesia in patients with sickle cell disease (SCD).

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
59 (actual)
First submitted
10 Jul 2024
Start date
7 Mar 2024
Primary completion date
30 Jan 2026
Lead sponsor
Indiana University
NCT number
NCT06511453

What you commit to

  • Study type: Interventional
  • Participants enrolled: 59
  • From 7 Mar 2024 to the primary completion date, 30 Jan 2026
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Presence of a concurrent autoimmune or inflammatory disease such as rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease, etc. that causes pain or any other chronic pain condition with pain greater than sickle pain.

Other illness

  • Diseases/conditions history includes but not limited to:
  • Known non-SCD-related severe psychiatric illnesses (e.g. current schizophrenia, major depression with suicidal ideation).
  • Significant visual, motor, or auditory impairment that would interfere with ability to perform study visits-related activities

Other

  • Recent/ongoing alternative pain management with acupuncture/acupressure or acupuncture/acupressure-related techniques within the last 6 months.
  • Head injury with substantial loss of consciousness

Who the study is looking for

  • Any gender
  • 18-80 (Adults) years old
  • Have been diagnosed with SCD and experiencing chronic pain in the past 6 months or vaso-occlusive crisis/crises in the past 12 months.
  • Either outpatient or inpatient or status changing between each other
  • Willing to limit the current and the introduction of any new medications or treatment modalities for control of pain symptoms during the study visits.
  • Willing to stick to the scheduled acupressure treatments every other day for 5 weeks.
  • Fluent in English and capable of giving written informed consent.

Age in the registry: 18 years to 80 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Indiana University School of Medicine
Coordinator of this site? Confirm its status
IndianapolisUnited StatesUnknown status
University of California, Irvine
Coordinator of this site? Confirm its status
IrvineUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.